Hantavirus Breakthrough Amid Cruise Outbreak

A deadly hantavirus outbreak on a cruise ship has reignited global concern over this rare, rodent-borne illness—with no vaccines or treatments currently available. While the virus rarely spreads between humans, the Andes strain is especially dangerous, killing up to 35% of U.S. cases and causing dozens of deaths in South America this year. But hope is emerging: early research suggests tocilizumab, a drug used for autoimmune diseases, may dramatically improve survival rates. With climate change driving more human-rodent contact and renewed public attention, scientists are pushing for faster progress—though funding and trial challenges remain steep barriers to bringing life-saving therapies to market. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/256fb73523fc55f6